282 related articles for article (PubMed ID: 17591770)
1. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.
Egerer M; Giesemann T; Jank T; Satchell KJ; Aktories K
J Biol Chem; 2007 Aug; 282(35):25314-21. PubMed ID: 17591770
[TBL] [Abstract][Full Text] [Related]
2. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
Egerer M; Giesemann T; Herrmann C; Aktories K
J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
[TBL] [Abstract][Full Text] [Related]
3. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
[TBL] [Abstract][Full Text] [Related]
4. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.
Hofmann F; Busch C; Prepens U; Just I; Aktories K
J Biol Chem; 1997 Apr; 272(17):11074-8. PubMed ID: 9111001
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
6. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
7. Processing of Clostridium difficile toxins.
Giesemann T; Egerer M; Jank T; Aktories K
J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.
Pruitt RN; Chagot B; Cover M; Chazin WJ; Spiller B; Lacy DB
J Biol Chem; 2009 Aug; 284(33):21934-21940. PubMed ID: 19553670
[TBL] [Abstract][Full Text] [Related]
9. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
10. Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.
Darkoh C; Kaplan HB; Dupont HL
J Clin Microbiol; 2011 Aug; 49(8):2933-41. PubMed ID: 21653766
[TBL] [Abstract][Full Text] [Related]
11. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
Schirmer J; Aktories K
Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
[TBL] [Abstract][Full Text] [Related]
12. Inositol hexakisphosphate-dependent processing of Clostridium sordellii lethal toxin and Clostridium novyi alpha-toxin.
Guttenberg G; Papatheodorou P; Genisyuerek S; Lü W; Jank T; Einsle O; Aktories K
J Biol Chem; 2011 Apr; 286(17):14779-86. PubMed ID: 21385871
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.
Dillon ST; Rubin EJ; Yakubovich M; Pothoulakis C; LaMont JT; Feig LA; Gilbert RJ
Infect Immun; 1995 Apr; 63(4):1421-6. PubMed ID: 7890404
[TBL] [Abstract][Full Text] [Related]
14. Structural organization of the functional domains of Clostridium difficile toxins A and B.
Pruitt RN; Chambers MG; Ng KK; Ohi MD; Lacy DB
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13467-72. PubMed ID: 20624955
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol-dependent pore formation of Clostridium difficile toxin A.
Giesemann T; Jank T; Gerhard R; Maier E; Just I; Benz R; Aktories K
J Biol Chem; 2006 Apr; 281(16):10808-15. PubMed ID: 16513641
[TBL] [Abstract][Full Text] [Related]
16. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
17. Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins.
Savidge TC; Urvil P; Oezguen N; Ali K; Choudhury A; Acharya V; Pinchuk I; Torres AG; English RD; Wiktorowicz JE; Loeffelholz M; Kumar R; Shi L; Nie W; Braun W; Herman B; Hausladen A; Feng H; Stamler JS; Pothoulakis C
Nat Med; 2011 Aug; 17(9):1136-41. PubMed ID: 21857653
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.
Rupnik M; Pabst S; Rupnik M; von Eichel-Streiber C; Urlaub H; Söling HD
Microbiology (Reading); 2005 Jan; 151(Pt 1):199-208. PubMed ID: 15632438
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine.
Jank T; Ziegler MO; Schulz GE; Aktories K
FEBS Lett; 2008 Jun; 582(15):2277-82. PubMed ID: 18505687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]